pharmaceutical productsの関連アイテムは見つかりませんでした。
|
![[EC Guide to Good Manufacturing Practice for Medicinal Products and Active Pharmaceutical Ingredients]の詳細ページへGO!](JavaScript:hre('http://www.wd-all.com/wd/pharmaceutical+products/','ama','3871932647','RUMgR3VpZGUgdG8gR29vZCBNYW51ZmFjdHVyaW5nIFByYWN0aWNlIGZvciBNZWRpY2luYWwgUHJvZHVjdHMgYW5kIEFjdGl2ZSBQaGFybWFjZXV0aWNhbCBJbmdyZWRpZW50cw==','http://images-jp.amazon.com/images/P/3871932647.90._BO2,127,255,255_PA10,5,10,5_AA100_SCTHUMBZZZ_.jpg','100','100'))
![[Pharmaceuticals and Personal Care Products in the Environment]の詳細ページへGO!](JavaScript:hre('http://www.wd-all.com/wd/pharmaceutical+products/','ama','6130470576','UGhhcm1hY2V1dGljYWxzIGFuZCBQZXJzb25hbCBDYXJlIFByb2R1Y3RzIGluIHRoZSBFbnZpcm9ubWVudA==','http://images-jp.amazon.com/images/P/6130470576.90._BO2,127,255,255_PA10,5,10,5_AA100_SCTHUMBZZZ_.jpg','100','100'))
|
![[Chemistry for Pharmacy Students: General, Organic and Natural Product Chemistry]の詳細ページへGO!](JavaScript:hre('http://www.wd-all.com/wd/pharmaceutical+products/','ama','0470017813','Q2hlbWlzdHJ5IGZvciBQaGFybWFjeSBTdHVkZW50czogR2VuZXJhbCwgT3JnYW5pYyBhbmQgTmF0dXJhbCBQcm9kdWN0IENoZW1pc3RyeQ==','http://images-jp.amazon.com/images/P/0470017813.90._BO2,127,255,255_PA10,5,10,5_AA100_SCTHUMBZZZ_.jpg','100','100'))
|
![[Pharmaceutical Lifecycle Management: Making the Most of Each and Every Brand]の詳細ページへGO!](JavaScript:hre('http://www.wd-all.com/wd/pharmaceutical+products/','ama','0470487534','UGhhcm1hY2V1dGljYWwgTGlmZWN5Y2xlIE1hbmFnZW1lbnQ6IE1ha2luZyB0aGUgTW9zdCBvZiBFYWNoIGFuZCBFdmVyeSBCcmFuZA==','http://images-jp.amazon.com/images/P/0470487534.90._BO2,127,255,255_PA10,5,10,5_AA100_SCTHUMBZZZ_.jpg','100','100'))
){kind=small}
){kind=small}
){kind=small}
|
![[Medicinal Natural Products: A Biosynthetic Approach]の詳細ページへGO!](JavaScript:hre('http://www.wd-all.com/wd/pharmaceutical+products/','ama','0470741678','TWVkaWNpbmFsIE5hdHVyYWwgUHJvZHVjdHM6IEEgQmlvc3ludGhldGljIEFwcHJvYWNo','http://images-jp.amazon.com/images/P/0470741678.90._BO2,127,255,255_PA10,5,10,5_AA100_SCTHUMBZZZ_.jpg','100','100'))
){kind=small}
){kind=small}
){kind=small}
){kind=small}
){kind=small}
検索サイトから【pharmaceutical products】関連ページ抽出
ＷＤＣＳの新レポート：捕鯨国は鯨油などの利用を目指している
... Corporation, an R&D oriented pharmaceutical company whose wholly owned subsidiary, the Seikagaku Biobusiness Corporation, supplies raw materials, including chondroitin sulfate, for pharmaceutical products and cosmetics. Seikagaku ...
... Corporation, an R&D oriented pharmaceutical company whose wholly owned subsidiary, the Seikagaku Biobusiness Corporation, supplies raw materials, including chondroitin sulfate, for pharmaceutical products and cosmetics. Seikagaku ...
ヨルダン：小麦輸入、医薬品輸出でカザフスタンと基本合意
... sides discussed matters relating to the pharmaceutical industry, especially regarding the ... the Kazakh people with Jordanian products. Rifai toured the centre, where locally made products, such as clothing, food, agricultural produce and Dead ...
... sides discussed matters relating to the pharmaceutical industry, especially regarding the ... the Kazakh people with Jordanian products. Rifai toured the centre, where locally made products, such as clothing, food, agricultural produce and Dead ...
急拡大するインド製薬産業
... Sun Pharmaceutical Industries は米国向けのジェネリックの抗癌剤と抗てんかん剤を大量生産している。 ... will enable the F.D.A. to “verify that important products and the way they are manufactured meet U.S. health and ...
... Sun Pharmaceutical Industries は米国向けのジェネリックの抗癌剤と抗てんかん剤を大量生産している。 ... will enable the F.D.A. to “verify that important products and the way they are manufactured meet U.S. health and ...
シリアの製薬産業は50ヶ国に合計2億ドル輸出、内需の91％を満たす
... (SANA) Recent statistics of the Arab Union of Pharmaceutical Manufacturers revealed that Syria is the second Arab exporter of ... Health Organization main list except blood derivative products, cancer drugs and vaccines. テーマ 経済 関連テーマ ...
... (SANA) Recent statistics of the Arab Union of Pharmaceutical Manufacturers revealed that Syria is the second Arab exporter of ... Health Organization main list except blood derivative products, cancer drugs and vaccines. テーマ 経済 関連テーマ ...
シリア・イラクが医薬品分野の協力で覚書調印
... that cooperation drug represents one of the most important areas where help bridge Iraq's need of pharmaceutical products and create new opportunities encouraging to investors the Syrians allow for the exchange of experiences and the ...
... that cooperation drug represents one of the most important areas where help bridge Iraq's need of pharmaceutical products and create new opportunities encouraging to investors the Syrians allow for the exchange of experiences and the ...
中国シノケム、DSMの抗感染症薬事業の50％を買収
... DSM の医薬部門は DSM Pharmaceutical Products と DSM Anti-Infectives から成る。 売上高は、 2009 2008 DSM Pharmaceutical Products 395 百万ユーロ 419 百万ユーロ DSM Anti-Infectives 326 444 合計 721 863 ...
... DSM の医薬部門は DSM Pharmaceutical Products と DSM Anti-Infectives から成る。 売上高は、 2009 2008 DSM Pharmaceutical Products 395 百万ユーロ 419 百万ユーロ DSM Anti-Infectives 326 444 合計 721 863 ...
8724、サムスン、バイオ医薬品受託生産参入、米クインタルズと合弁、16年から産業レベルで後発薬生産
... North Carolina, USA Key people Dennis Gillings, Chairman & CEO John Ratliff President & COO Products Support services for pharmaceutical, biotech and medical companies and individuals Revenue US$Approaching 3.0 billion Employees ...
... North Carolina, USA Key people Dennis Gillings, Chairman & CEO John Ratliff President & COO Products Support services for pharmaceutical, biotech and medical companies and individuals Revenue US$Approaching 3.0 billion Employees ...
RE: Statin drug development corruption: the evidence
... malpractice is the third leading cause of death in the US and in many other countries. If you add in all the carcinogens they put in our daily products then you can say the pharmaceutical and chemical industries are the world's worst mass ...
... malpractice is the third leading cause of death in the US and in many other countries. If you add in all the carcinogens they put in our daily products then you can say the pharmaceutical and chemical industries are the world's worst mass ...
医薬品市場の貿易障壁撤廃反対！☆カナダ
... other jurisdictions," said Keon. "The pharmaceutical intellectual property proposals tabled by the EU, however, are not intended to eliminate trade barriers, as brand-name pharmaceutical products from the EU already have unfettered access ...
... other jurisdictions," said Keon. "The pharmaceutical intellectual property proposals tabled by the EU, however, are not intended to eliminate trade barriers, as brand-name pharmaceutical products from the EU already have unfettered access ...
中国ライフサイエンス企業の買収における問題点
... Permit: domestic manufacturers of pharmaceutical products must hold this permit. Good Manufacturing Practices (GMP) Certification: domestic manufacturers of pharmaceutical products must hold this certification. Anti-Monopoly Law Issues ... tDiary 本日のリンク元
... Permit: domestic manufacturers of pharmaceutical products must hold this permit. Good Manufacturing Practices (GMP) Certification: domestic manufacturers of pharmaceutical products must hold this certification. Anti-Monopoly Law Issues ... tDiary 本日のリンク元
